Pharmacological Identification of a Guanidine-Containing β-Alanine Analogue with Low Micromolar Potency and Selectivity for the Betaine/GABA Transporter 1 (BGT1)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurochemical Research

• Publication date

  2014-05-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11064-014-1336-9PMID 24852577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel GABA(A) receptor agonists.

  2014cited by this paper
• Synaptic inhibition and γ-aminobutyric acid in the mammalian central nervous system

  2013cited by this paper
• Selective mGAT2 (BGT-1) GABA uptake inhibitors: design, synthesis, and pharmacological characterization.

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Transporters

  2013cited by this paper
• Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile.

  2013cited by this paper
• A Steered Molecular Dynamics Study of Binding and Translocation Processes in the GABA Transporter

  2012cited by this paper
• The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface.

  2012cited by this paper
• The GABA system in anxiety and depression and its therapeutic potential.

  2012cited by this paper
• Development of an (S)‐1‐{2‐[Tris(4‐methoxyphenyl)methoxy]ethyl}piperidine‐3‐carboxylic acid [(S)‐SNAP‐5114] Carba Analogue Inhibitor for Murine γ‐Aminobutyric Acid Transporter Type 4

  2012cited by this paper
• GABA system dysfunction in autism and related disorders: from synapse to symptoms.

  2012cited by this paper
• Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice.

  2011cited by this paper
• GABAergic drugs in the treatment of epilepsy: modern or outmoded?

  2011cited by this paper
• Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol

  2011cited by this paper
• SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation

  2011cited by this paper
• GABA transport inhibitors and seizure protection: the past and future.

  2011cited by this paper
• Mutations in GABAA receptor subunits associated with genetic epilepsies

  2010cited by this paper
• Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs.

  2010cited by this paper
• The four human gamma-aminobutyric acid (GABA) transporters: pharmacological characterization and validation of a highly efficient screening assay.

  2009cited by this paper
• GABA Neurotransmission: An Overview

  2008cited by this paper
• Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC).

  2008cited by this paper
• Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology

  2007cited by this paper
• Cloning and Characterization of a Functional Human γ-Aminobutyric Acid (GABA) Transporter, Human GAT-2*

  2007cited by this paper
• Structure-activity relationships of selective GABA uptake inhibitors.

  2006cited by this paper
• GABA Transporter Deficiency Causes Tremor, Ataxia, Nervousness, and Increased GABA-Induced Tonic Conductance in Cerebellum

  2005cited by this paper
• Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues.

  2005cited by this paper
• First Demonstration of a Functional Role for Central Nervous System Betaine/γ-Aminobutyric Acid Transporter (mGAT2) Based on Synergistic Anticonvulsant Action among Inhibitors of mGAT1 and mGAT2

  2005cited by this paper
• Novel parent structures for inhibitors of the murine GABA transporters mGAT3 and mGAT4.

  2005cited by this paper
• GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.

  2004cited by this paper
• Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.

  2004cited by this paper
• GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus.

  2003cited by this paper
• Correlation between Anticonvulsant Activity and Inhibitory Action on Glial γ-Aminobutyric Acid Uptake of the Highly Selective Mouse γ-Aminobutyric Acid Transporter 1 Inhibitor 3-Hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and ItsN-Alkylated Analogs

  2002cited by this paper
• GABA mechanisms and sleep.

  2002cited by this paper
• Molecular Characterization of Four Pharmacologically Distinct a-Aminobutyric Acid Transporters in Mouse Brain *

  2001cited by this paper
• GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.

  2000cited by this paper
• GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.

  2000cited by this paper
• Structure and subunit composition of GABA(A) receptors.

  1999cited by this paper
• Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site.

  1994cited by this paper
• Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected].

  1993cited by this paper
• Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.

  1991cited by this paper
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

  1987cited by this paper

• 1,3,5-Triazinanes as C-N-C three-atom synthons in cycloaddition with β-aminocrotononitrile: Synthesis and structure of novel tetrahydropyrimidines

  2026cites this paper
• Structural basis for selective inhibition of human GABA transporter GAT3

  2025cites this paper
• Rational Search for Betaine/GABA Transporter 1 Inhibitors—In Vitro Evaluation of Selected Hit Compound

  2024cites this paper
• Ways of modulating GABA transporters to treat neurological disease

  2024cites this paper
• In vitro characterization of taurine transport using the human brain microvascular endothelial cell line as a human blood-brain barrier model.

  2024cites this paper
• Structural and stereochemical determinants for hGAT3 inhibition: development of novel conformationally constrained and substituted analogs of (S)-isoserine

  2023cites this paper
• Synthesis of Cyclic N-Acyl Amidines by [3 + 2] Cycloaddition of N-Silyl Enamines and Activated Acyl Azides

  2022cites this paper
• Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters

  2021cites this paper
• Molecular Determinants and Pharmacological Analysis for a Class of Competitive Non-transported Bicyclic Inhibitors of the Betaine/GABA Transporter BGT1

  2021cites this paper
• An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters

  2021cites this paper
• Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABAA receptors

  2020cites this paper
• Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects

  2020cites this paper
• γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases.

  2020cites this paper
• Exploring the molecular determinants for subtype-selectivity of 2-amino-1,4,5,6-tetrahydropyrimidine-5-carboxylic acid analogs as betaine/GABA transporter 1 (BGT1) substrate-inhibitors

  2020cites this paper
• Feedback adaptation of synaptic excitability via Glu:Na+ symport driven astrocytic GABA and Gln release.

  2019cites this paper
• Five-membered N-heterocyclic Scaffolds as Novel Amino Bioisosteres at -Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters.

  2019cites this paper
• Structural and molecular aspects of betaine-GABA transporter 1 (BGT1) and its relation to brain function.

  2019cites this paper
• GAT3 selective substrate l-isoserine upregulates GAT3 expression and increases functional recovery after a focal ischemic stroke in mice

  2017cites this paper
• Glial GABA Transporters as Modulators of Inhibitory Signalling in Epilepsy and Stroke.

  2017cites this paper
• Pharmacological Characterization of [3H]ATPCA as a Substrate for Studying the Functional Role of the Betaine/GABA Transporter 1 and the Creatine Transporter.

  2017cites this paper
• Development of Non-GAT1-Selective Inhibitors: Challenges and Achievements.

  2017cites this paper
• Impact of SLC6A Transporters in Physiological Taurine Transport at the Blood-Retinal Barrier and in the Liver.

  2016cites this paper
• Structure activity relationship of selective GABA uptake inhibitors.

  2015cites this paper
• Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.

  2015cites this paper